The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.
Cytotoxic lymphocytes (CLs) contain lysosome-related organelles (LROs) that perform the normal degradative functions of the lysosome, in addition to storage and release of powerful cytotoxins employed to kill virally infected or abnormal cells. Among these cytotoxins is granzyme B (GrB), a protease that has also been implicated in activation (restimulation)-induced cell death of natural killer (NK) and T cells, but the underlying mechanism and its regulation are unclear. Here we show that restimulation of previously activated human or mouse lymphocytes induces lysosomal membrane permeabilisation (LMP), followed by GrB release from LROs into the CL cytosol. The model lysosomal stressors sphingosine and Leu-Leu-methyl-ester, and CLs from gene-targeted mice were used to show that LMP releases GrB in both a time- and concentration-dependent manner, and that the liberated GrB is responsible for cell death. The endogenous GrB inhibitor Serpinb9 (Sb9) protects CLs against LMP-induced death but is decreasingly effective as the extent of LMP increases. We also used these model stressors to show that GrB is the major effector of LMP-mediated death in T cells, but that in NK cells additional effectors are released, making GrB redundant. We found that limited LMP and GrB release occurs constitutively in proliferating lymphocytes and in NK cells engaged with targets in vitro. In Ectromelia virus-infected lymph nodes, working NK cells lacking Sb9 are more susceptible to GrB-mediated death. Taken together, these data show that a basal level of LMP occurs in proliferating and activated lymphocytes, and is increased on restimulation. LMP releases GrB from LROs into the lymphocyte cytoplasm and its ensuing interaction with Sb9 dictates whether or not the cell survives. The GrB-Sb9 nexus may therefore represent an additional mechanism of limiting lymphocyte lifespan and populations.
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia.
C H
CH
Bird
Apoptosis and Cytotoxicity Laboratory, Mater Medical Research Institute, Brisbane, QLD, Australia.
M E
ME
Christensen
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia.
M S J
MS
Mangan
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia.
M D
MD
Prakash
Cancer Cell Death, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
K A
KA
Sedelies
Cancer Cell Death, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
M J
MJ
Smyth
Monash Micro Imaging, Monash University, Melbourne, VIC, Australia.
I
I
Harper
Apoptosis and Cytotoxicity Laboratory, Mater Medical Research Institute, Brisbane, QLD, Australia.
N J
NJ
Waterhouse
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia.
P I
PI
Bird
D000818:Animals; D016923:Cell Death / Q000187:drug effects*; D002463:Cell Membrane Permeability / Q000187:drug effects; D053804:Granzymes / Q000378:metabolism*; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D051379:Mice; D015843:Serpins / Q000378:metabolism*; D013110:Sphingosine / Q000494:pharmacology; D013312:Stress, Physiological / Q000187:drug effects / Q000235:genetics*; D013601:T-Lymphocytes / Q000187:drug effects
C102316:SERPINB9 protein, human; D015843:Serpins; D053804:Granzymes; D013110:Sphingosine